Antimicrobial therapy of ventilator-associated pneumonia: How to select an appropriate drug regimen

Chest

Volumn 115, Issue 1, 1999, Pages 8-11

  Kollef, M H ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT;

ACINETOBACTER; ANTIBIOTIC RESISTANCE; ANTIMICROBIAL THERAPY; ARTIFICIAL VENTILATION; BACTERIAL PNEUMONIA; BACTERIUM CULTURE; EDITORIAL; ESCHERICHIA COLI; HAEMOPHILUS INFLUENZAE; HEALTH CARE COST; HOSPITAL INFECTION; HUMAN; KLEBSIELLA PNEUMONIAE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MORTALITY; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; VENTILATOR;

EID: 0032939640     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.115.1.8     Document Type: Editorial

References (19)

1. JL Vincent DJ Bihari PM Suter The prevalence of nosocomial infection in intensive care units in Europe: results of the European Prevalence of Infection in Intensive Care (EPIC) Study: EPIC International Advisory Committee JAMA 274 1995 639 644
2. MH Kollef L Sharpless J Vlasnik The impact of noscomial infections on patient outcomes following cardiac surgery Chest 12 1997 666 675
3. DE Craven KA Steger Ventilator-associated bacterial pneumonia: challenges in diagnosis, treatment, and prevention New Horiz 6 1998 S30 S45
4. MH Kollef Ventilator-associated pneumonia: an update for clinicians Respir Care 40 1995 1130 1140
5. HS Leu DL Kaiser M Mori Hospital-acquired pneumonia: attributable mortality and morbidity Am J Epidemiol 129 1989 1258 1267
6. JY Fagon J Chastre AJ Hance Nosocomial pneumonia in ventilated patients: a cohort study evaluating attributable mortality and hospital stay Am J Med 94 1993 281 288
7. Public health focus: Surveillance, prevention, and control of nosocomial infections MMWR 41 1992 783 787
8. WR Jarvis Selected aspects of the socioeconomic impact of nosocomial infections: morbidity, mortality, cost, and prevention Infect Control Hosp Epidemiol 17 1996 552 557
9. JM Boyce G Potter-Bynoe L Dziobek Nosocomial pneumonia in Medicare patients: hospital costs and reimbursement patterns under the prospective payment system Arch Intern Med 151 1991 1109 1114
10. CM Luna P Vujacich MS Niederman Impact of BAL data on the therapy and outcome of ventilator-associated pneumonia Chest 111 1997 676 685
11. F Alvarez-Lerma Modification of empiric antibiotic treatment in patients with pneumonia acquired in the intensive care unit: ICU-Acquired Pneumonia Study Group Intensive Care Med 22 1996 387 394
12. J Rello M Gallego D Mariscal The value of routine microbial investigation in ventilator-associated pneumonia Am J Respir Crit Care Med 156 1997 196 200
13. MH Kollef S Ward The influence of mini-BAL cultures on patient outcomes: implications for the antibiotic management of ventilator associated pneumonia Chest 113 1998 412 420
14. JY Fagon J Chastre Y Domart Mortality due to ventilator-associated pneumonia or colonization with Psuedomonas or Acinetobacteria species: assessment by quantitative culture of samples obtained by a protected specimen brush Clin Infect Dis 23 1996 538 542
15. MH Kollef P Silver DM Murphy The effect of late-onset ventilator-associated pneumonia in determining patient mortality Chest 108 1995 1655 1662
16. P Dore' R Robert G Grollier Incidence of anaerobes in ventilator-associated pneumonia with use of a protected specimen brush Am J Respir Crit Care Med 153 1996 1292 1298
17. DN Gerding S Johnson LR Peterson Clostridium difficile -associated diarrhea and colitis Infect Control Hosp Epidemiol 16 1995 459 477
18. MW Climo DS Israel ES Wong Hospital-wide restriction of clindamycin: effect on the incidence of Clostridum difficile -associated diarrhea and cost Ann Intern Med 128 1998 989 995
19. JL Trouillet J Chastre A Vuagnat Ventilator-associated pneumonia caused by potentially drug-resistant bacteria Am J Respir Crit Care Med 157 1998 531 539